Filter
34
Filtered Results: 34
Text search:
European
Society
of
Clinical
Microbiology
and
Infectious
Diseases
EUCAST
Featured
Recommendations
1
New Publications
2
Language
Document type
Studies & Reports
22
Guidelines
7
No document type
2
Manuals
1
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
Nigeria
2
Ghana
2
Malawi
2
Burkina Faso
1
Sierra Leone
1
Senegal
1
Ethiopia
1
Cameroon
1
Uganda
1
Zimbabwe
1
Nepal
1
Pakistan
1
Zambia
1
Kenya
1
Tanzania
1
Eswatini/ Swaziland
1
Colombia
1
Western Pacific Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
Global
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
17
Toolboxes
AMR
31
TB
2
Planetary Health
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, inclu...
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description ... practices, how they were implemented, achievements, and why the practice was unique.
Copenhagen, Denmark, 24–25 August 2017
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of ...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries ... territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth GLASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
